303 related articles for article (PubMed ID: 11878894)
21. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
22. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.
Kellam P; Boshoff C; Whitby D; Matthews S; Weiss RA; Talbot SJ
J Hum Virol; 1997; 1(1):19-29. PubMed ID: 10195227
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
Verma SC; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
[TBL] [Abstract][Full Text] [Related]
24. Minichromosome Maintenance Proteins Cooperate with LANA during the G
Dabral P; Uppal T; Rossetto CC; Verma SC
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
[TBL] [Abstract][Full Text] [Related]
25. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.
Staudt MR; Dittmer DP
Virology; 2006 Jun; 350(1):192-205. PubMed ID: 16616289
[TBL] [Abstract][Full Text] [Related]
26. Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes.
Gao SJ; Zhang YJ; Deng JH; Rabkin CS; Flore O; Jenson HB
J Infect Dis; 1999 Nov; 180(5):1466-76. PubMed ID: 10515805
[TBL] [Abstract][Full Text] [Related]
27. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
[TBL] [Abstract][Full Text] [Related]
28. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
Verma SC; Choudhuri T; Kaul R; Robertson ES
J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
[TBL] [Abstract][Full Text] [Related]
29. Lack of a mechanism for faithful partition and maintenance of the KSHV genome.
Ueda K; Sakakibara S; Ohsaki E; Yada K
Virus Res; 2006 Dec; 122(1-2):85-94. PubMed ID: 16920214
[TBL] [Abstract][Full Text] [Related]
30. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.
Hellert J; Weidner-Glunde M; Krausze J; Lünsdorf H; Ritter C; Schulz TF; Lührs T
Proc Natl Acad Sci U S A; 2015 May; 112(21):6694-9. PubMed ID: 25947153
[TBL] [Abstract][Full Text] [Related]
31. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins.
Han SJ; Hu J; Pierce B; Weng Z; Renne R
J Gen Virol; 2010 Sep; 91(Pt 9):2203-15. PubMed ID: 20484563
[TBL] [Abstract][Full Text] [Related]
33. KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence.
Komatsu T; Ballestas ME; Barbera AJ; Kelley-Clarke B; Kaye KM
Virology; 2004 Feb; 319(2):225-36. PubMed ID: 14980483
[TBL] [Abstract][Full Text] [Related]
34. Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.
Vázquez Ede L; Carey VJ; Kaye KM
J Virol; 2013 Nov; 87(22):12270-83. PubMed ID: 24006437
[TBL] [Abstract][Full Text] [Related]
35. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
[TBL] [Abstract][Full Text] [Related]
36. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Garber AC; Shu MA; Hu J; Renne R
J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
[TBL] [Abstract][Full Text] [Related]
37. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.
Verma SC; Choudhuri T; Robertson ES
J Virol; 2007 Apr; 81(7):3402-13. PubMed ID: 17151118
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
39. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
40. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]